Impact of Vector Priming on the Immunogenicity of RecombinantSalmonellaVaccines
Open Access
- 1 January 2003
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (1) , 287-297
Abstract
There are conflicting reports concerning the impact of prior vector priming on the immunogenicity of recombinant-Salmonella-based vaccines. A comparison of experimental protocols identified two variables which might account for this inconsistency: the potential of the vector strain to colonize the murine gut-associated lymphoid tissue (GALT) and the nature of the foreign antigen subsequently delivered by the recombinant Salmonella construct. The former was investigated by constructing an aroA mutant of the Salmonella enterica serovar Stanley vector previously used in our laboratory. Although the introduction of an aroA mutation had surprisingly little effect on GALT colonization, it did reduce the strength of antilipopolysaccharide (anti-LPS) antibody responses and the impact of vector priming. Studies were also performed to ascertain the extent to which any observed hyporesponsiveness consequent upon vector priming might be determined by the characteristics of the foreign antigen. S. enterica serovar Stanley was used to deliver either of two Escherichia coli antigens, K88 pilus protein or the LT-B toxin subunit, to vector-primed mice. Both serum immunoglobulin G (IgG) and intestinal IgA responses to K88 were completely abolished, and those to LT-B were significantly reduced, as a consequence of vector priming. When similar experiments were performed with an aroA S. enterica serovar Dublin vector, responses to K88 were significantly reduced but those to LT-B were unaffected by vector priming. Paradoxically, a priming infection with this vector induced stronger anti-LPS antibody responses but was less likely to elicit a state of hyporesponsiveness to subsequently presented foreign antigen. The impact of vector priming thus depends on both the Salmonella strain used and the nature of the foreign antigen, but our present data strengthen concerns that preexisting antivector immunity represents a serious threat to the Salmonella-based vaccine strategy.Keywords
This publication has 21 references indexed in Scilit:
- Induction of Protective Immunity againstStreptococcus mutansColonization after Mucosal Immunization with AttenuatedSalmonella entericaSerovar Typhimurium Expressing anS. mutansAdhesin under the Control of In Vivo-InduciblenirBPromoterInfection and Immunity, 2001
- Aromatic-dependent Salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding themJournal of Biotechnology, 2000
- Effect of Preexisting Immunity to Salmonella on the Immune Response to Recombinant Salmonella enterica Serovar Typhimurium Expressing a Porphyromonas gingivalis HemagglutininInfection and Immunity, 2000
- Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strainVaccine, 1997
- The molecular basis for the virulence of bacterial pathogens: implications for oral vaccine developmentMicrobiology, 1994
- Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigensClinical Microbiology Reviews, 1992
- A wide-host-range suicide vector for improving reverse genetics in Gram-negative bacteria: inactivation of the blaA gene of Yersinia enterocoliticaGene, 1991
- A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strainsMicrobial Pathogenesis, 1988
- Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune systemParasite Immunology, 1987
- Cloning mapping and expression of the genetic determinant that encodes for the K88ab antigenNucleic Acids Research, 1979